Earnings History Data for ACADIA Pharmaceuticals Inc. (ACAD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-08-2024 AH ACAD ACADIA Pharmaceuticals Inc. 3,140 0.20 0.16 0.01 Acadia Pharma GAAP EPS of $0.20 beats by $0.03, revenue of $241.96M beats by $6.3M
[8/6/2024 4:28 PM]
15.19 -3.67 
(-19.44%)
15.39 -3.46 
(-18.36%)
14.55 - 32.59 6,421,052 2,000,000 69,510
08-05-2024 AH ACAD ACADIA Pharmaceuticals Inc. 2,800 0.10 0.16 -0.27 Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M
[5/8/2024 4:10 PM]
15.20 -1.93 
(-11.30%)
17.00 -0.13 
(-0.76%)
15.18 - 33.99 4,644,637 1,590,000 3,432
27-02-2024 AH ACAD ACADIA Pharmaceuticals Inc. 4,070 0.28 0.32 -0.26 Acadia Pharma GAAP EPS of $0.28 misses by $0.02, revenue of $231.04M beats by $7.24M
[2/27/2024 4:11 PM]
23.64 -2.71 
(-10.30%)
24.55 -1.81 
(-6.87%)
17.71 - 33.99 4,274,046 1,740,000 3,036
02-11-2023 AH ACAD ACADIA Pharmaceuticals Inc. 3,700 -0.40 -0.43 -0.17 Acadia Pharma GAAP EPS of -$0.40 beats by $0.05, revenue of $211.7M beats by $22.08M
[11/2/2023 4:15 PM]
24.09 1.11 
(4.81%)
23.81 0.82 
(3.57%)
13.73 - 33.99 2,253,713 1,420,000 19,364
02-08-2023 AH ACAD ACADIA Pharmaceuticals Inc. 4,760 0.01 -0.12 -0.21 Acadia Pharma GAAP EPS of $0.01 beats by $0.07, revenue of $165.3M beats by $7.46M
[8/2/2023 4:15 PM]
27.29 -1.91 
(-6.54%)
27.86 -1.34 
(-4.59%)
13.73 - 33.99 3,303,660 1,870,000 2,286
08-05-2023 AH 4:05 PM ET
(May 8)
ACAD ACADIA Pharmaceuticals Inc. 3,500 -0.27 -0.21 -0.70 ACADIA Pharma GAAP EPS of -$0.27 misses by $0.06, revenue of $118.46M misses by $1.83M
[5/8/2023 4:07 PM]
21.43 -0.12 
(-0.53%)
21.67 0.12 
(0.56%)
12.24 - 22.11 1,470,706 1,270,000 26,428
27-02-2023 AH 4:05 PM ET
(Feb 27)
ACAD ACADIA Pharmaceuticals Inc. 3,070 -0.26 -0.25 -0.27 ACADIA Pharma GAAP EPS of -$0.26 misses by $0.02, revenue of $136.49M beats by $1.31M
[2/27/2023 4:08 PM]
20.72 1.32 
(6.81%)
19.40 0.0 
(0.00%)
12.24 - 28.06 2,749,815 1,240,000 257,073
02-11-2022 AH 4:05 PM ET
(Nov 2)
ACAD ACADIA Pharmaceuticals Inc. 2,590 -0.17 -0.18 -0.09 ACADIA Pharma GAAP EPS of -$0.17 beats by $0.02, revenue of $130.71M misses by $8.33M
[11/2/2022 4:20 PM]
14.87 -1.06 
(-6.69%)
15.50 -0.43 
(-2.70%)
12.24 - 28.05 3,305,095 1,340,000 148,238
08-08-2022 AH 4:05 PM ET
(Aug 8)
ACAD ACADIA Pharmaceuticals Inc. 2,330 -0.21 -0.25 -0.27 ACADIA Pharma GAAP EPS of -$0.21 beats by $0.05, revenue of $134.56M beats by $4.5M
[8/8/2022 4:11 PM]
16.23 -0.39 
(-2.35%)
16.35 -0.27 
(-1.62%)
12.24 - 28.05 2,566,548 1,830,000 515
04-05-2022 AH 4:05 PM ET
(May 4)
ACAD ACADIA Pharmaceuticals 2,973 -0.70 -0.49 0.00 ACADIA Pharma GAAP EPS of -$0.70 misses by $0.13, revenue of $115.5M misses by $6.72M
[5/4/2022 4:24 PM]
18.82 -1.07 
(-5.38%)
19.50 -0.39 
(-1.96%)
15.68 - 28.05 1,009,708 1,740,000 366
28-02-2022 AH 4:05 PM ET
(Feb 28)
ACAD ACADIA Pharmaceuticals Inc. 4,150 -0.27 -0.24 -0.42 ACADIA Pharma GAAP EPS of -$0.27 misses by $0.04, revenue of $130.8M misses by $4.64M
[2/28/2022 4:10 PM]
25.07 -0.34 
(-1.34%)
24.15 -1.26 
(-4.96%)
15.68 - 49.91 1,501,458 1,240,000 1,331
08-11-2021 AH 4:05 PM ET
(Nov 8)
ACAD ACADIA Pharmaceuticals Inc. 3,220 -0.09 -0.27 -0.54 ACADIA Pharma EPS beats by $0.17, beats on revenue
[11/8/2021 4:24 PM]
21.62 2.05 
(10.48%)
20.74 1.17 
(5.98%)
15.68 - 57.46 1,518,729 1,270,000 5,416
04-08-2021 AH 4:10 PM ET
(Aug 4)
ACAD ACADIA Pharmaceuticals Inc. 3,360 -0.27 -0.30 -0.27 ACADIA Pharma EPS beats by $0.03, misses on revenue; FY21 guidance lowered
[8/4/2021 4:22 PM]
19.38 -1.67 
(-7.93%)
19.86 -1.19 
(-5.65%)
19.10 - 57.46 2,619,131 1,410,000 23,816
05-05-2021 AH 4:05 PM ET
(May 5)
ACAD ACADIA Pharmaceuticals Inc. 3,290 -0.42 -0.53 -0.57 ACADIA Pharma EPS beats by $0.12, misses on revenue
[5/5/2021 4:15 PM]
20.94 1.54 
(7.94%)
19.50 0.10 
(0.52%)
19.20 - 58.72 2,298,534 1,680,000 3,614
24-02-2021 AH 4:05 PM ET
(Feb 24)
ACAD ACADIA Pharmaceuticals Inc. 7,980 -0.42 -0.48 -0.34 ACADIA Pharma EPS beats by $0.05, misses on revenue
[2/24/2021 4:07 PM]
47.31 -1.38 
(-2.83%)
49.50 0.81 
(1.66%)
30.02 - 58.72 1,005,605 787,548 1,161
04-11-2020 AH 4:05 PM ET
(Nov 4)
ACAD ACADIA Pharmaceuticals Inc. 7,250 -0.54 -0.38 -0.29 ACADIA Pharma EPS misses by $0.18, beats on revenue
[11/4/2020 4:08 PM]
48.56 -0.57 
(-1.16%)
46.88 -2.25 
(-4.58%)
30.02 - 58.72 1,427,921 1,336,501 6,182
05-08-2020 AH 4:05 PM ET
(Aug 5)
ACAD ACADIA Pharmaceuticals Inc. 6,480 -0.27 -0.44 -0.38 ACADIA Pharma EPS beats by $0.18, beats on revenue
[8/5/2020 4:07 PM]
43.52 0.65 
(1.52%)
43.00 0.13 
(0.30%)
23.77 - 58.72 1,317,205 1,436,097 4,545